Secondary Logo

Journal Logo

Articles by Anu Osinusi

P-B4 Predictors of sustained viral response to 4–6 week duration therapy with Ledipasvir + Sofosbuvir + Gs-9451 +/− Gs-9669 in early and advanced fibrosis (Nih-Ihv synergy trial)

Kattakuzhy, Sarah; Wilson, Eleanor; Tang, Lydia; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 71:73, January 2016.

P-B11 Retreatment of HCV GT-1 in patients who failed previous short course combination DAA therapy with 12 weeks of LDV/SOF is highly effective

Wilson, Eleanor; Kattakuzhy, Sarah; Tang, Lydia; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 71:77, January 2016.

Gene Expression Profiles Predict Emergence of Psychiatric Adverse Events in HIV/HCV-Coinfected Patients on Interferon-Based HCV Therapy

Rasimas, Joseph; Katsounas, Antonios; Raza, Haniya; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 60(3):273-281, July 1st, 2012.

HIV/Hepatitis C Virus−Coinfected Virologic Responders to Pegylated Interferon and Ribavirin Therapy More Frequently Incur Interferon-Related Adverse Events Than Nonresponders Do

Osinusi, Anu; Rasimas, Joseph J; Bishop, Rachel; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 53(3):357-363, March 1st, 2010.